Chemicals & Advanced Materials Global On demand · 24-48h

Global Liquid Acid Protease Enzyme Market Strategic Research Report

Global Liquid Acid Protease Enzyme Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Liquid Acid Protease Enzyme Market
$1062025
6.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Microbial Source, Animal Source, Plant Source

By Application: Food, Feed, Leather, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Novonesis (CPH: NZYM B, Bagsværd Denmark), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Amano Enzyme Inc. (TYO: 2802, Nagoya Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Creative Enzymes (Unlisted, New York USA), Biocatalysts Ltd. (Unlisted, Wales UK), SunHY(Unlisted, Hubei China), Hunan Hongying Biological Technology Co., Ltd. (Unlisted, Hunan China), Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China), Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China), Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China), Sunsonzyme (Unlisted, Beijing China), Wilton Bioscience (Unlisted, Gujarat India), Enzyme Bioscience Pvt. Ltd. (Unlisted, Gujarat India)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 135 pages
Market size 2025
$106
Million USD
Forecast CAGR
6.2%
2025-2032
Forecast 2032
$161.5
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Liquid Acid Protease Enzyme market size is predicted to grow from US$ 106 million in 2025 to US$ 161 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Liquid acid protease enzyme is a protease preparation that maintains high catalytic activity under acidic conditions and mainly exists in liquid form. Its production is primarily aimed at efficiently and specifically hydrolyzing proteins to solve the technical challenges of protein processing and modification under acidic conditions in the food, feed, and other industrial sectors. Demand mainly comes from: the food industry (e.g., cheese curdling, meat tenderizing, baking improvement, soybean protein hydrolysis); the feed industry (improving the digestibility and absorption of animal feed, especially young animal feed); and other fields (leather dehairing, wool shrinkage prevention, detergent additives, etc.). Upstream suppliers mainly include strain research (enzyme-producing strains such as Aspergillus niger and Yersinia lipolyticis), fermentation raw material suppliers (soybean meal, corn steep liquor, etc.), and fermentation equipment manufacturers; downstream applications are widespread among end-users such as food processing plants, feed production enterprises, and tanneries. In 2025, the production of liquid acid protease enzyme was approximately 12,000 tons, with an average price of approximately US$9,000 per ton, a gross profit margin of approximately 30%, and a single-line capacity of 200 tons per year.

Global key Liquid Acid Protease Enzyme players cover Novonesis (CPH: NZYM B, Bagsværd Denmark), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liquid Acid Protease Enzyme market?

What factors are driving Liquid Acid Protease Enzyme market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liquid Acid Protease Enzyme market opportunities vary by end market size?

How does Liquid Acid Protease Enzyme break out by Type, by Application?

This report presents a comprehensive overview of the global Liquid Acid Protease Enzyme market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Microbial Source
  • Animal Source
  • Plant Source

Segment by Product Form

  • Standard Liquid Formulation
  • High-Activity Liquid Formulation
  • Stabilized Liquid Formulation

Segment by Application

  • Food
  • Feed
  • Leather
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Liquid Acid Protease Enzyme market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Food, Feed, Leather evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Liquid Acid Protease Enzyme Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$106
2025
Forecast
$161.5
2032
CAGR
6.2%
2025–2032
Regions
5
global
Key companies
Novonesis (CPH: NZYM BBagsværd Denmark)DSM-Firmenich AG (SIX: DSMFKaiseraugst Switzerland)AB Enzymes GmbH (UnlistedDarmstadt Germany)Guangdong VTR Bio-Tech Co.Ltd. (SZSE: 300381
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Microbial SourceAnimal SourcePlant Source
By Application
FoodFeedLeatherOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Microbial Source
  • 3.1.3 Animal Source
  • 3.1.4 Plant Source
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Food
  • 4.1.3 Feed
  • 4.1.4 Leather
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Novonesis (CPH: NZYM B, Bagsværd Denmark)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 AB Enzymes GmbH (Unlisted, Darmstadt Germany)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Amano Enzyme Inc. (TYO: 2802, Nagoya Japan)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Creative Enzymes (Unlisted, New York USA)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Biocatalysts Ltd. (Unlisted, Wales UK)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 SunHY(Unlisted, Hubei China)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hunan Hongying Biological Technology Co., Ltd. (Unlisted, Hunan China)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sunsonzyme (Unlisted, Beijing China)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Wilton Bioscience (Unlisted, Gujarat India)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Enzyme Bioscience Pvt. Ltd. (Unlisted, Gujarat India)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Liquid Acid Protease Enzyme market size?
The global Liquid Acid Protease Enzyme market is estimated at US$ 106 million in 2025 (base year) and is projected to reach US$ 161 million by 2032.
What growth rate is expected for the Liquid Acid Protease Enzyme market through 2032?
The market is expected to grow at a CAGR of 6.2% from 2026 to 2032, expanding from US$ 106 million in 2025 to US$ 161 million in 2032, roughly 1.5 times its base-year value.
How is Liquid Acid Protease Enzyme defined?
Liquid acid protease enzyme is a protease preparation that maintains high catalytic activity under acidic conditions and mainly exists in liquid form. Its production is primarily aimed at efficiently and specifically hydrolyzing proteins to solve the technical challenges of protein processing and modification under acidic conditions in the food, feed, and other industrial sectors.
What are the main segments of the Liquid Acid Protease Enzyme market by type?
By type, the market is segmented into Microbial Source, Animal Source and Plant Source.
Which applications drive demand in the Liquid Acid Protease Enzyme market?
Key applications covered include Food, Feed, Leather and Other.
Who are the key players in the Liquid Acid Protease Enzyme market?
Key players profiled include Novonesis (CPH: NZYM B, Bagsværd Denmark), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), Amano Enzyme Inc. (TYO: 2802, Nagoya Japan), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India) and Creative Enzymes (Unlisted, New York USA), among 17 companies covered in total.
Which regions and countries are covered for Liquid Acid Protease Enzyme?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Liquid Acid Protease Enzyme market?
What factors are driving Liquid Acid Protease Enzyme market growth, globally and by region?
What challenges does the Liquid Acid Protease Enzyme market face?
Its production is primarily aimed at efficiently and specifically hydrolyzing proteins to solve the technical challenges of protein processing and modification under acidic conditions in the food, feed, and other industrial sectors.
Who should buy the Liquid Acid Protease Enzyme market report?
The report is intended for manufacturers and solution providers, distributors and end users in Food, Feed and Leather, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Liquid Acid Protease Enzyme market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.